Compounded Ketamine: Understanding Custom-Prepared Ketamine Formulations

As ketamine therapy has expanded beyond hospital anesthesia departments into psychiatric and pain management clinics, a growing number of patients are encountering compounded ketamine -- custom-prepared formulations made by specialty pharmacies. From troches and nasal sprays to rapid-dissolve tablets and topical creams, compounded ketamine encompasses the full spectrum of non-IV, non-FDA-approved ketamine products.

Understanding what compounded ketamine is, how it differs from FDA-approved treatments, and how to evaluate quality is essential for any patient considering at-home ketamine therapy. This guide provides a comprehensive overview of all compounded formulations, quality considerations, and practical guidance for safe use.

What Is Compounded Ketamine?

Compounding is the practice of creating customized medications tailored to individual patient needs. A licensed compounding pharmacist combines pharmaceutical-grade ingredients to produce medications in specific doses, forms, and formulations that are not available as commercial products.

Compounded ketamine refers to any ketamine preparation made by a compounding pharmacy, as opposed to commercially manufactured products. The source material is pharmaceutical-grade racemic ketamine powder (the same chemical compound used in hospital anesthesia), which is then formulated into various delivery forms.

Why Compound Ketamine?

The FDA approved ketamine as an injectable anesthetic in 1970. It was never specifically approved in lozenge, nasal spray, or cream form for psychiatric or pain conditions. Since pharmaceutical companies have not marketed these formulations commercially, compounding pharmacies fill the gap by creating them based on provider prescriptions.

This is legal and common in medicine -- compounding pharmacies create many medications that are not commercially available in the needed form, dose, or combination. However, it does mean that compounded ketamine products have not undergone the rigorous FDA approval process that commercial drugs go through.

Types of Compounded Ketamine

Troches (Lozenges)

Ketamine troches are the most commonly prescribed compounded form:

• How it works: Dissolves slowly in the mouth (sublingual/buccal absorption)
• Bioavailability: ~25-30%
• Typical dose: 50-300 mg per troche
• Cost: $50-$150 per dose
• Best for: At-home maintenance therapy after clinical treatment series
• Key consideration: Requires 15-20 minutes of holding in mouth; expectorate after

Nasal Spray

Compounded ketamine nasal spray offers higher absorption than oral routes:

• How it works: Sprayed into nasal passages for mucosal absorption
• Bioavailability: ~25-50%
• Typical dose: 30-80 mg per session (multiple sprays)
• Cost: $100-$200 per bottle (5-10 sessions)
• Best for: Patients preferring nasal over oral routes; rapid-onset maintenance
• Key consideration: Absorption affected by nasal congestion

Rapid-Dissolve Tablets (RDTs)

RDTs are an alternative sublingual format:

• How it works: Placed under the tongue, dissolves in 2-5 minutes
• Bioavailability: ~25-30% (similar to troches)
• Typical dose: 50-200 mg per tablet
• Cost: $50-$150 per dose
• Best for: Patients who struggle with the 15-20 minute troche hold time
• Key consideration: Faster dissolution may mean slightly lower absorption

Oral Liquid Solution

Liquid formulations for sublingual use:

• How it works: Measured liquid held under the tongue for 10-15 minutes
• Bioavailability: ~25-30%
• Typical dose: 50-200 mg per measured dose
• Cost: $100-$300 per bottle (multiple doses)
• Best for: Precise dose adjustment (can measure exact volumes)
• Key consideration: Bitter taste; some patients prefer troches for palatability

Topical Cream/Gel

Ketamine cream is primarily used for pain conditions:

• How it works: Applied to the skin over the painful area for local absorption
• Bioavailability: Very low systemically (primarily local action)
• Typical concentration: 5-10% ketamine, often combined with other analgesics
• Cost: $100-$300 per tube
• Best for: Localized neuropathic pain, CRPS, post-surgical pain
• Key consideration: Minimal systemic effects; may also include other compounded ingredients (gabapentin, baclofen, etc.)

Quality and Safety Considerations

The Quality Gap

Not all compounding pharmacies are created equal. Unlike FDA-approved drugs that must meet strict manufacturing standards (Current Good Manufacturing Practice or cGMP), compounding pharmacies operate under different regulatory frameworks:

• Federal oversight: FDA oversees compounders under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act
• State oversight: State boards of pharmacy regulate day-to-day compounding operations
• Voluntary accreditation: PCAB (Pharmacy Compounding Accreditation Board) provides optional quality certification

What Can Go Wrong

Quality issues that have been documented in compounding pharmacies include:

• Potency errors: Products containing more or less ketamine than labeled
• Contamination: Microbial or chemical contamination from improper preparation
• Stability issues: Products that degrade faster than the assigned expiration date
• Inconsistent dosing: Batch-to-batch variation in drug content
• Improper formulation: Using inappropriate excipients or bases that affect absorption

How to Evaluate Pharmacy Quality

When your provider prescribes compounded ketamine, ask about the pharmacy's credentials:

Must-haves:

• PCAB accreditation (Pharmacy Compounding Accreditation Board) or equivalent
• USP 795 compliance (non-sterile compounding standards)
• USP 797 compliance (if preparing sterile formulations)
• Licensed in the state(s) where they ship

Strong indicators of quality:

• Third-party potency testing on finished products
• Beyond-use dating based on stability studies (not just default expiration)
• Pharmacist available for consultation about formulation questions
• Clear labeling: active ingredient, dose, lot number, expiration, storage instructions
• Established relationship with your prescribing provider

Red flags:

• No accreditation or quality certifications
• Unwilling to share testing data
• Prices dramatically lower than comparable pharmacies
• Willing to fill prescriptions from unlicensed or unverified providers
• No patient or provider consultation available

Research Evidence

Efficacy of Compounded Formulations

Research on compounded ketamine formulations collectively demonstrates that non-IV routes can produce clinically meaningful antidepressant and analgesic effects when appropriately dosed:

Al Shirawi et al. (2020): A systematic review of oral ketamine (encompassing troches, RDTs, and liquid formulations) for treatment-resistant depression found that these compounded forms produced significant antidepressant effects across multiple studies, supporting their use as alternatives to IV administration.

Topical ketamine research (2019): A review of topical ketamine for neuropathic pain found moderate evidence supporting its use for localized pain conditions, particularly when combined with other topical analgesics in compound formulations.

Safety Data

Compounding quality studies (2021): Research examining the quality of compounded ketamine products from multiple pharmacies found significant variation in potency between pharmacies, reinforcing the importance of using accredited, quality-certified compounders.

The American Psychiatric Association's 2017 consensus statement acknowledges that while IV remains the most studied route, other formulations may offer practical alternatives for maintenance therapy, provided quality and safety standards are maintained.

Compounded Ketamine vs. FDA-Approved Options

When Compounded Makes Sense

• At-home maintenance: After establishing response with clinical treatment, compounded forms enable affordable home-based maintenance
• Cost sensitivity: Compounded ketamine is typically the most affordable ongoing option
• Chronic pain topicals: No FDA-approved ketamine topical exists for pain
• Geographic access: Patients in rural areas can receive compounded medications by mail
• Provider preference: Some clinicians prefer the dosing flexibility of compounded forms

When FDA-Approved May Be Better

• Insurance coverage needed: Spravato is often covered by insurance
• Quality assurance priority: FDA-approved products have guaranteed consistency
• Initial treatment: IV ketamine offers the highest bioavailability and most research
• Regulatory comfort: Some patients prefer the assurance of FDA approval
• Severe symptoms: Clinical-grade treatment may be more appropriate for acute crises

Cost Overview

Typical Monthly Costs by Formulation

| Formulation | Frequency | Monthly Cost | |-------------|-----------|-------------| | Troches (maintenance) | 2x/week | $400-$1,200 | | Nasal spray (maintenance) | 2x/week | $160-$480 | | RDTs (maintenance) | 2x/week | $400-$1,200 | | Topical cream (daily) | Daily | $100-$300 | | Telehealth subscription (all-inclusive) | Varies | $200-$400 |

Insurance and Payment

• Insurance: Compounded ketamine is generally not covered by insurance
• HSA/FSA: Typically eligible as prescribed medications
• Cost comparison guide: Detailed pricing across all treatment types
• Payment options: Financing for ketamine therapy

How to Get Compounded Ketamine

The Process

1. Evaluation: See a qualified provider (psychiatrist, pain specialist, or ketamine-experienced clinician) for assessment
2. Prescription: If appropriate, your provider writes a prescription specifying the formulation, dose, and quantity
3. Pharmacy selection: The prescription is sent to a compounding pharmacy (your provider may have preferred relationships)
4. Preparation: The pharmacy compounds your medication to specification
5. Delivery: Medication is shipped to you or available for pickup
6. Monitoring: Regular follow-up appointments with your prescribing provider to assess response and adjust as needed

Finding a Provider

Search our clinic directory to find providers experienced in prescribing compounded ketamine formulations. Look for providers who:

• Have established relationships with accredited compounding pharmacies
• Offer structured protocols for at-home compounded ketamine use
• Provide regular monitoring and follow-up
• Can explain the rationale for choosing compounded vs. clinical treatment

Regulatory Landscape

Current Regulation

Compounded ketamine exists in a regulatory space that is evolving:

• Schedule III controlled substance: All ketamine products require a prescription; DEA registration for prescribers and pharmacies
• Section 503A compounders: Traditional compounding pharmacies that fill individual prescriptions
• Section 503B outsourcing facilities: Larger-scale compounders with additional FDA oversight
• State variation: Some states have additional requirements for compounded controlled substances
• Telehealth prescribing: Federal and state regulations on prescribing controlled substances via telehealth are evolving, particularly after the COVID-era telehealth flexibilities

What Patients Should Know

• Always obtain compounded ketamine through a legitimate prescription from a licensed provider
• Verify your compounding pharmacy's credentials and accreditation
• Be wary of online sources selling ketamine without a valid prescription process
• Report any quality concerns to your state board of pharmacy
• Keep compounded ketamine securely stored as a controlled substance

Is Compounded Ketamine Right for You?

Compounded ketamine may be appropriate if you:

• Need an at-home maintenance option after clinical treatment
• Want the most affordable form of ongoing ketamine therapy
• Need topical treatment for localized pain conditions
• Prefer the flexibility of home-based dosing
• Live in an area with limited access to ketamine clinics

Talk with your provider about which compounded formulation -- if any -- is right for your situation. The most important factors are working with a qualified prescriber and using an accredited compounding pharmacy. Find a qualified ketamine provider to start the conversation.